Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

SRx Health Solutions (SRXH) EBIT (2016 - 2025)

Historic EBIT for SRx Health Solutions (SRXH) over the last 16 years, with Q2 2025 value amounting to -$17.4 million.

  • SRx Health Solutions' EBIT fell 121785.17% to -$17.4 million in Q2 2025 from the same period last year, while for Jun 2025 it was -$11.1 million, marking a year-over-year increase of 4182.57%. This contributed to the annual value of $4.2 million for FY2024, which is 11979.32% up from last year.
  • Latest data reveals that SRx Health Solutions reported EBIT of -$17.4 million as of Q2 2025, which was down 121785.17% from -$1.1 million recorded in Q1 2025.
  • SRx Health Solutions' 5-year EBIT high stood at $8.5 million for Q4 2024, and its period low was -$24.2 million during Q4 2022.
  • Moreover, its 5-year median value for EBIT was -$3.6 million (2022), whereas its average is -$5.1 million.
  • As far as peak fluctuations go, SRx Health Solutions' EBIT surged by 16688.67% in 2024, and later crashed by 121785.17% in 2025.
  • Quarter analysis of 5 years shows SRx Health Solutions' EBIT stood at -$5.0 million in 2021, then crashed by 385.37% to -$24.2 million in 2022, then skyrocketed by 47.33% to -$12.7 million in 2023, then surged by 166.89% to $8.5 million in 2024, then plummeted by 304.72% to -$17.4 million in 2025.
  • Its EBIT stands at -$17.4 million for Q2 2025, versus -$1.1 million for Q1 2025 and $8.5 million for Q4 2024.